The Therapeutics Development and Implementation (TDI) Component provides educational and collaborative resources focused on therapeutics development and implementation to basic and clinical scientists.
By leveraging new resources and reducing barriers to effective and meaningful integration of the “right end” of the translational research continuum into the research development activities of those working at the earlier stages of the translational continuum (i.e., bench, clinical trials), we seek to accelerate the favorable public health impact of translational research.
The TDI team has specific strengths in economic analysis (including pharmacoeconomics). We will support investigators in their efforts to translate research into products and services and develop community-focused dissemination strategies. For more information about TDI and the Tufts CTSI Industry Advisory Board visit here.
Contact: Component Co-Directors Peter Neumann, ScD, Kenneth Kaitin, PhD, and Richard Karas, MD, PhD.
